CLOV Rises Prior Earnings on November 8th

During the last session, 10M of Clover Health Investments, Corp.’s (NasdaqGS:CLOV) shares were traded. The stock closed at $7.82 per share indicating that it gained $0.32 or 4.27% during that day which brings the Clover Health Investments, Corp.’s valuation to $3.21B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -72.89% from that peak but still a -24.92% gain since the share price dropped to a 52-week low of $6.31, while the S&P 500’s share price change was of 36.69%.


What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen decay in its daily volume. The daily volume was of 23M, while in the last 10 days the average was 7.49M and last three months – 23.24M.

Shrinking short interest

The Clover Health Investments, Corp.’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 29.16M shares being shorted which translates into 1.81 of a short ratio for CLOV, while in the previous month the shorted shares were 31.02M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of 3.21B, Clover Health Investments, Corp. holds a total cash of $607.15M that translates into $1.48 per share, while the total debt is of $29.14M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 109.70%. The current revenue is of $921.74M that is $4.69 per share.

This is a great sign for a bright future.